You Show Me Yours, and I’ll Show You Mine: President Unveils International Family Planning Funding Increase in Budget Request

Together, we can advance the right to essential health care and bodily autonomy in the year ahead. Give Today
This update outlines what you need to know about the court case attacking access to mifepristone, one of two drugs most commonly used in medication abortion in the United States, as of March 10, 2023. It describes what has happened and what is at stake if the FDA approval for mifepristone is rescinded. This update also outlines potential implications globally and provides clear and actionable next steps to learn more about this case and monitor similar threats to abortion access.
Stay informed about the issues impacting sexual and reproductive health and rights.